KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Adaptive Biotechnologies (ADPT) Receivables - Net (2018 - 2025)

Adaptive Biotechnologies' Receivables - Net history spans 8 years, with the latest figure at $50.4 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 20.69% year-over-year to $50.4 million; the TTM value through Dec 2025 reached $50.4 million, up 20.69%, while the annual FY2025 figure was $50.4 million, 20.69% up from the prior year.
  • Receivables - Net for Q4 2025 was $50.4 million at Adaptive Biotechnologies, up from $44.8 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $50.4 million in Q4 2025 and bottomed at $14.2 million in Q2 2021.
  • The 5-year median for Receivables - Net is $33.6 million (2023), against an average of $32.8 million.
  • The largest annual shift saw Receivables - Net soared 130.09% in 2022 before it decreased 5.21% in 2023.
  • A 5-year view of Receivables - Net shows it stood at $17.4 million in 2021, then skyrocketed by 130.09% to $40.1 million in 2022, then fell by 5.21% to $38.0 million in 2023, then grew by 9.91% to $41.7 million in 2024, then grew by 20.69% to $50.4 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Receivables - Net are $50.4 million (Q4 2025), $44.8 million (Q3 2025), and $44.3 million (Q2 2025).